title: Polo-like kinase 1 inhibitors SBE13 and BI 2536 induce different responses in primary cells.
authors.forename: Frank
authors.initials: F
authors.lastname: Eckerdt
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D001596:Benzylamines / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects*; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D002478:Cells, Cultured / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D011621:Pteridines / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D013379:Substrate Specificity / Q000235:genetics; D000097869:Polo-Like Kinase 1
chemical_list: D001596:Benzylamines; D018797:Cell Cycle Proteins; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D011621:Pteridines; D011725:Pyridines; D000097869:Polo-Like Kinase 1; C518477:BI 2536; C549033:SBE13 compound